DC markers HLA-DR, CD86, CD1c, ILT3 and CD40 did not significantly differ among the outcome groups in mitochondrial populations, however their expression was significantly elevated in the melanoma bad and good outcome groups as compared to HD in the glycolytic cell states (Fig. 4C). The gene discussed is CD86; the disease is melanoma.